182 related articles for article (PubMed ID: 20630585)
1. The importance of endo-lysosomal escape with lipid nanocapsules for drug subcellular bioavailability.
Paillard A; Hindré F; Vignes-Colombeix C; Benoit JP; Garcion E
Biomaterials; 2010 Oct; 31(29):7542-54. PubMed ID: 20630585
[TBL] [Abstract][Full Text] [Related]
2. Lipid nanocarriers improve paclitaxel transport throughout human intestinal epithelial cells by using vesicle-mediated transcytosis.
Roger E; Lagarce F; Garcion E; Benoit JP
J Control Release; 2009 Dec; 140(2):174-81. PubMed ID: 19699246
[TBL] [Abstract][Full Text] [Related]
3. Post-insertion into Lipid NanoCapsules (LNCs): From experimental aspects to mechanisms.
Perrier T; Saulnier P; Fouchet F; Lautram N; Benoît JP
Int J Pharm; 2010 Aug; 396(1-2):204-9. PubMed ID: 20600733
[TBL] [Abstract][Full Text] [Related]
4. Antibacterial action of lipid nanocapsules containing fatty acids or monoglycerides as co-surfactants.
Umerska A; Cassisa V; Matougui N; Joly-Guillou ML; Eveillard M; Saulnier P
Eur J Pharm Biopharm; 2016 Nov; 108():100-110. PubMed ID: 27597268
[TBL] [Abstract][Full Text] [Related]
5. Reciprocal competition between lipid nanocapsules and P-gp for paclitaxel transport across Caco-2 cells.
Roger E; Lagarce F; Garcion E; Benoit JP
Eur J Pharm Sci; 2010 Aug; 40(5):422-9. PubMed ID: 20438839
[TBL] [Abstract][Full Text] [Related]
6. Development and characterization of immuno-nanocarriers targeting the cancer stem cell marker AC133.
Bourseau-Guilmain E; Béjaud J; Griveau A; Lautram N; Hindré F; Weyland M; Benoit JP; Garcion E
Int J Pharm; 2012 Feb; 423(1):93-101. PubMed ID: 21683129
[TBL] [Abstract][Full Text] [Related]
7. Lipid nanocapsules loaded with an organometallic tamoxifen derivative as a novel drug-carrier system for experimental malignant gliomas.
Allard E; Passirani C; Garcion E; Pigeon P; Vessières A; Jaouen G; Benoit JP
J Control Release; 2008 Sep; 130(2):146-53. PubMed ID: 18582507
[TBL] [Abstract][Full Text] [Related]
8. Long-circulating DNA lipid nanocapsules as new vector for passive tumor targeting.
Morille M; Montier T; Legras P; Carmoy N; Brodin P; Pitard B; Benoît JP; Passirani C
Biomaterials; 2010 Jan; 31(2):321-9. PubMed ID: 19800113
[TBL] [Abstract][Full Text] [Related]
9. A new generation of anticancer, drug-loaded, colloidal vectors reverses multidrug resistance in glioma and reduces tumor progression in rats.
Garcion E; Lamprecht A; Heurtault B; Paillard A; Aubert-Pouessel A; Denizot B; Menei P; Benoît JP
Mol Cancer Ther; 2006 Jul; 5(7):1710-22. PubMed ID: 16891457
[TBL] [Abstract][Full Text] [Related]
10. Inner ear biocompatibility of lipid nanocapsules after round window membrane application.
Zhang Y; Zhang W; Löbler M; Schmitz KP; Saulnier P; Perrier T; Pyykkö I; Zou J
Int J Pharm; 2011 Feb; 404(1-2):211-9. PubMed ID: 21075187
[TBL] [Abstract][Full Text] [Related]
11. Lipid nanocapsules: ready-to-use nanovectors for the aerosol delivery of paclitaxel.
Hureaux J; Lagarce F; Gagnadoux F; Vecellio L; Clavreul A; Roger E; Kempf M; Racineux JL; Diot P; Benoit JP; Urban T
Eur J Pharm Biopharm; 2009 Oct; 73(2):239-46. PubMed ID: 19560538
[TBL] [Abstract][Full Text] [Related]
12. Lipid nanocapsules for intracellular drug delivery of anticancer drugs.
Lacoeuille F; Garcion E; Benoit JP; Lamprecht A
J Nanosci Nanotechnol; 2007 Dec; 7(12):4612-7. PubMed ID: 18283853
[TBL] [Abstract][Full Text] [Related]
13. Formulation and nebulization of fluticasone propionate-loaded lipid nanocarriers.
Umerska A; Mouzouvi CR; Bigot A; Saulnier P
Int J Pharm; 2015 Sep; 493(1-2):224-32. PubMed ID: 26183331
[TBL] [Abstract][Full Text] [Related]
14. Surfactant dependent toxicity of lipid nanocapsules in HaCaT cells.
Maupas C; Moulari B; Béduneau A; Lamprecht A; Pellequer Y
Int J Pharm; 2011 Jun; 411(1-2):136-41. PubMed ID: 21463666
[TBL] [Abstract][Full Text] [Related]
15. Layer-by-layer surface modification of lipid nanocapsules.
Hirsjärvi S; Qiao Y; Royere A; Bibette J; Benoit JP
Eur J Pharm Biopharm; 2010 Oct; 76(2):200-7. PubMed ID: 20656028
[TBL] [Abstract][Full Text] [Related]
16. Galactosylated DNA lipid nanocapsules for efficient hepatocyte targeting.
Morille M; Passirani C; Letrou-Bonneval E; Benoit JP; Pitard B
Int J Pharm; 2009 Sep; 379(2):293-300. PubMed ID: 19505548
[TBL] [Abstract][Full Text] [Related]
17. Oil-encapsulating PEO-PPO-PEO/PEG shell cross-linked nanocapsules for target-specific delivery of paclitaxel.
Bae KH; Lee Y; Park TG
Biomacromolecules; 2007 Feb; 8(2):650-6. PubMed ID: 17291088
[TBL] [Abstract][Full Text] [Related]
18. Administration-dependent efficacy of ferrociphenol lipid nanocapsules for the treatment of intracranial 9L rat gliosarcoma.
Huynh NT; Passirani C; Allard-Vannier E; Lemaire L; Roux J; Garcion E; Vessieres A; Benoit JP
Int J Pharm; 2012 Feb; 423(1):55-62. PubMed ID: 21536115
[TBL] [Abstract][Full Text] [Related]
19. The adaptation of lipid nanocapsule formulations for blood administration in animals.
Hureaux J; Lagarce F; Gagnadoux F; Clavreul A; Benoit JP; Urban T
Int J Pharm; 2009 Sep; 379(2):266-9. PubMed ID: 19467305
[TBL] [Abstract][Full Text] [Related]
20. Surface active properties of lipid nanocapsules.
Mouzouvi CRA; Umerska A; Bigot AK; Saulnier P
PLoS One; 2017; 12(8):e0179211. PubMed ID: 28796777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
